Literature DB >> 23541463

Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies.

Chrystèle Locher1, Didier Debieuvre, Daniel Coëtmeur, François Goupil, Olivier Molinier, Thierry Collon, Charles Dayen, Jacques Le Treut, Bernard Asselain, Francis Martin, François Blanchon, Michel Grivaux.   

Abstract

The incidence of lung cancer has dramatically increased in ten years, being now the most commonly diagnosed cancer in males and the fourth most commonly diagnosed cancer in females. Considering social and scientific evolution, the aim of the present study conducted by the French College of General Hospital Respiratory Physicians (CPHG) was to compare patient and lung cancer characteristics at a ten-year interval. Two epidemiological studies, KBP-2000-CPHG and KBP-2010-CPHG, were conducted at a ten-year interval. These prospective multicentre studies included all patients ≥ 18 years of age with primary lung cancer diagnosed between 1st January and 31st December 2000 or 2010, and managed in the respiratory departments of one of the participating general hospitals. A standardised form was completed for each patient. A steering committee checked recruitment exhaustiveness. Respectively, in 2000 and 2010, 137 and 104 centres included 5667 and 7051 patients. Compared to 2000, patients in 2010 were significantly older (65.5 ± 11.3 vs. 64.3 ± 11.5 years, p < 0.0001), more frequently women (24.3% vs. 16.0%, p < 0.0001) and never-smokers (10.9% vs. 7.2%, p < 0.0001). In 2010, adenocarcinoma was the most common tumour (45.4%, vs. 29.0% in 2000, p < 0.0001). The adenocarcinoma rate increased irrespective of sex, age, or smoking status (relative risk [RR] before and after adjustment, RR = 2.07 [1.92-2.24], p < 0.0001 and 2.06 [1.90-2.23], p < 0.0001). In ten years, lung cancer characteristics have therefore changed: more women, more never-smokers, and more adenocarcinomas. The particular high increase in adenocarcinoma rate deserves further analysis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541463     DOI: 10.1016/j.lungcan.2013.03.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  17 in total

1.  Concerns About Lung Cancer Among Prisoners.

Authors:  Luc Renault; Emmanuel Perrot; Eric Pradat; Christophe Bartoli; Laurent Greillier; Anne Remacle-Bonnet; Norbert Telmon; Julien Mazières; Laurent Molinier; Sébastien Couraud
Journal:  Lung       Date:  2018-01-03       Impact factor: 2.584

2.  New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases.

Authors:  Charles Dayen; Didier Debieuvre; Olivier Molinier; Olivier Raffy; Fabrice Paganin; Jérôme Virally; Sébastien Larive; Béatrice Desurmont-Salasc; Marielle Perrichon; Francis Martin; Michel Grivaux
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Women have a higher resection rate for lung cancer and improved survival after surgery.

Authors:  Anna Lautamäki; Jarmo Gunn; Jussi Sipilä; Päivi Rautava; Eero Sihvo; Ville Kytö
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-27

4.  Mandible bone metastases secondary to pulmonary adenocarcinoma.

Authors:  Nigar Dirican; Sedat Gunes; Yeliz Karakaya; Vildan Kaya; Sureyya Cerci; Ahmet Dirican
Journal:  Med Arch       Date:  2014-10-15

5.  Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer.

Authors:  Gilles Quéré; Renaud Descourt; Gilles Robinet; Sandrine Autret; Odile Raguenes; Brigitte Fercot; Pierre Alemany; Arnaud Uguen; Claude Férec; Isabelle Quintin-Roué; Gérald Le Gac
Journal:  BMC Cancer       Date:  2016-03-11       Impact factor: 4.430

6.  Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.

Authors:  Sylvie Leroy; Jonathan Benzaquen; Andrea Mazzetta; Sylvain Marchand-Adam; Bernard Padovani; Dominique Israel-Biet; Christophe Pison; Pascal Chanez; Jacques Cadranel; Julien Mazières; Vincent Jounieaux; Charlotte Cohen; Véronique Hofman; Marius Ilie; Paul Hofman; Charles Hugo Marquette
Journal:  BMJ Open       Date:  2017-12-26       Impact factor: 2.692

7.  Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).

Authors:  Christos Chouaïd; Didier Debieuvre; Isabelle Durand-Zaleski; Jérôme Fernandes; Arnaud Scherpereel; Virginie Westeel; Cécile Blein; Anne-Françoise Gaudin; Nicolas Ozan; Soline Leblanc; Alexandre Vainchtock; Pierre Chauvin; François-Emery Cotté; Pierre-Jean Souquet
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

8.  Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank.

Authors:  Isabelle Stücker; Diane Martin; Monica Neri; Pierre Laurent-Puig; Hélène Blons; Martine Antoine; Anne Guiochon-Mantel; Sylvie Brailly-Tabard; Marianne Canonico; Marie Wislez; Jean Trédaniel
Journal:  BMC Public Health       Date:  2017-04-17       Impact factor: 3.295

9.  Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?

Authors:  Mélanie Deberne; Stanislas Ropert; Bertrand Billemont; Catherine Daniel; Jeanne Chapron; François Goldwasser
Journal:  BMC Cancer       Date:  2014-06-10       Impact factor: 4.430

10.  Early mortality in lung cancer: French prospective multicentre observational study.

Authors:  Michel Grivaux; Didier Debieuvre; Dominique Herman; Christine Lemonnier; Jean-Michel Marcos; Jacky Crequit; Sylvie Vuillermoz-Blas; Patricia Barre; Marie Saillour; Francis Martin
Journal:  BMC Pulm Med       Date:  2016-04-02       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.